TW200509990A - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
TW200509990A
TW200509990A TW093117060A TW93117060A TW200509990A TW 200509990 A TW200509990 A TW 200509990A TW 093117060 A TW093117060 A TW 093117060A TW 93117060 A TW93117060 A TW 93117060A TW 200509990 A TW200509990 A TW 200509990A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical formulations
formulations
clavulanate
stabilise
amoxicillin
Prior art date
Application number
TW093117060A
Other languages
English (en)
Inventor
Michael Gale Ramsey
Jill Tracy Rickman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of TW200509990A publication Critical patent/TW200509990A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW093117060A 2003-06-16 2004-06-14 Pharmaceutical formulations TW200509990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47876903P 2003-06-16 2003-06-16
GBGB0313913.6A GB0313913D0 (en) 2003-06-16 2003-06-16 New use

Publications (1)

Publication Number Publication Date
TW200509990A true TW200509990A (en) 2005-03-16

Family

ID=27636629

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093117060A TW200509990A (en) 2003-06-16 2004-06-14 Pharmaceutical formulations

Country Status (6)

Country Link
US (1) US20050136117A1 (zh)
CN (1) CN1809348A (zh)
AR (1) AR044697A1 (zh)
GB (1) GB0313913D0 (zh)
TW (1) TW200509990A (zh)
ZA (1) ZA200510098B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007002924A1 (de) * 2007-01-19 2008-07-24 Bayer Healthcare Ag ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung
KR20140117523A (ko) 2012-01-10 2014-10-07 마이클 스펙터 아목시실린 및 클라불란산 칼륨의 소아용 경구 현탁 제형 및 이를 사용하기 위한 방법
CN102614174B (zh) * 2012-02-24 2014-04-30 南京臣功制药股份有限公司 含有阿莫西林和克拉维酸钾的干混悬剂
CN104345100A (zh) * 2014-08-29 2015-02-11 四川制药制剂有限公司 同时测定阿莫西林克拉维酸钾血药浓度的方法
CN114668724B (zh) * 2020-12-24 2023-08-22 鲁南制药集团股份有限公司 一种阿莫西林克拉维酸钾干混悬剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1078627T3 (da) * 1999-08-20 2006-11-13 Glaxosmithkline Lab Sas Farmaceutisk præparat omfattende amoxillin og clavulanat

Also Published As

Publication number Publication date
US20050136117A1 (en) 2005-06-23
GB0313913D0 (en) 2003-07-23
CN1809348A (zh) 2006-07-26
AR044697A1 (es) 2005-09-21
ZA200510098B (en) 2007-04-25

Similar Documents

Publication Publication Date Title
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
AU2003267203A1 (en) Method for administering thermotherapy to prevent the growth of tumors
AU2003238023A1 (en) Method of evaluating myelosuppressive state
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
AU2002221702A1 (en) Pharmaceutical compositions
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
TNSN05222A1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
NO20055882L (no) Farmasoytiske formuleringer omfattende amoksicillin og klavulanat
TW200508233A (en) Chk-1 inhibitors
SG162766A1 (en) Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
TW200509990A (en) Pharmaceutical formulations
GEP20125525B (en) Stable liquid pharmaceutical composition based on trazodone
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
DE60322228D1 (de) Schnell zerfallende tablette
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines
TW200509794A (en) Novel anthelmintic and insecticidal compositions
AU2003291368A1 (en) Compounds for the treatment of tobacco dependence and withdrawal
ATE253555T1 (de) Vitamin d-analogen und ihre pharmazeutische verwendung
EP1652525A4 (en) ANTI-CORONAVIRUS MEDICINE